Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

71.51USD
24 May 2013
Price Change (% chg)

$-0.64 (-0.89%)
Prev Close
$72.15
Open
$72.05
Day's High
$72.07
Day's Low
$71.33
Volume
703,413
Avg. Vol
808,260
52-wk High
$73.95
52-wk Low
$48.98

BAX.N

Chart for BAX.N

About

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.... (more)

Overall

Beta: 0.51
Market Cap (Mil.): $38,754.99
Shares Outstanding (Mil.): 541.95
Dividend: 0.49
Yield (%): 2.74

Financials

  BAX.N Industry Sector
P/E (TTM): 17.23 34.04 34.30
EPS (TTM): 4.15 -- --
ROI: 15.69 19.04 18.43
ROE: 33.46 19.78 19.30
Search Stocks

Baxter's Alzheimer's disease drug fails in late-stage trial

NEW YORK - In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.

07 May 2013

UPDATE 2-Baxter's Alzheimer's disease drug fails in late-stage trial

* Baxter to stop late-stage studies of the drug for mild to moderate Alzheimer's

07 May 2013

BRIEF-Baxter shares down after drug fails in late-stage trial

NEW YORK, May 7 - Baxter International Inc : * Shares down 2.6 percent in premarket trade after alzeheimer's drug fail

07 May 2013

Baxter's Alzheimer's disease drug fails in late-stage trial

May 7 - Baxter International Inc said a late-stage study of its experimental drug to treat Alzheimer's disease failed to reduce the decline of cognitive functions and preserve functional abilities.

07 May 2013

Baxter posts lower earnings on acquisition-related expenses

- Baxter International Inc on Thursday said quarterly net earnings fell slightly, as expected, on acquisition-related costs.

18 Apr 2013

UPDATE 2-Baxter posts lower earnings on acquisition-related expenses

* Strength in Bioscience division offset weakness in medical products unit

18 Apr 2013

Baxter posts lower earnings on acquisition-related expenses

- Baxter International Inc on Thursday said its quarterly net earnings fell slightly, as expected, on acquisition-related costs.

18 Apr 2013

Baxter posts lower earnings on acqusition-related expenses

April 18 - Baxter International Inc on Thursday said its quarterly net earnings fell slightly, even as sales rose, as acquisition-related costs ate into profits.

18 Apr 2013

Manatee death toll rises in Florida even as toxic algae ebbs

TAMPA, Florida - A deadly algae bloom that killed a record number of manatees has dissipated, though the death toll for the endangered sea mammals continues to rise, Florida wildlife officials said on Thursday.

04 Apr 2013

Baxter profit higher; sales seen rising 10 percent in 2013

- Medical device and bioscience company Baxter International Inc reported higher quarterly earnings on Thursday and forecast sales growth of 10 percent for 2013.

24 Jan 2013

Competitors

Earnings vs. Estimates

Search Stocks